Dr Charis Teh
WEHI (The Walter and Eliza Hall Institute of Medical Research)
$449,997
2025 - 2028
The Research
Immunotherapy, where the body's own immune system fights cancer, is effective in only a minority of patients. Therefore, new targets are urgently needed to improve outcomes.
Our study explores a new immunotherapeutic strategy that targets regulatory T (Treg) cells, which are present in solid cancers and a poor prognostic indicator. We will target 'suicide switches' to kill Treg cells and boost anti-cancer responses.
This work could lead to new treatment options for patients with solid cancers.
share
.svg)
